Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Print


Guest: Welcome to ChinaBio
® Today!

As a guest to ChinaBio® Today, you have access to summaries of over 3000 articles including our archives.  You can use the Search feature on the left menu bar to find what you're looking for, or you can browse summaries of our articles by the categories listed under Subscriber Articles. You can access any article that is marked as FREE. Or you can subscribe and have access to our entire content.   

Top Stories

>> See all top stories...


Recent Articles

Recent Articles

  GrandOmics of Beijing Raises $14 Million for Third-Gen Sequencing (in: Deals & Financings)
  BeiGene and Cancer Genetics Form Precision Medicine Collaboration (in: Deals & Financings)
  BioAtla and Sinobioway Select Four Drug Candidates: Deal Now Worth $100+ Million (in: Deals & Financings)
  China-Prevalent Form of NSCLC Responds to AstraZeneca Drug (in: Trials & Approvals)
  JHL Forms $257 Million Partnership with Sanofi for Rituximab Biosimilar (in: Deals & Financings)
  Week in Review: Suzhou's Innovent Biologics Announces Record $260 Million Funding (in: Week in Review)
  Luye Closes $269 Million Acquisition of Swiss Pharma's Patch Business (in: Deals & Financings)
  Uni-Bio and Beijing Sun-Novo to Co-Develop Diabetes Treatments (in: Deals & Financings)
  Beijing's Novogene Closes $75 Million B Round for Genomic Sequencing (in: Deals & Financings)
  Alphamab/3D Medicines PD-L1 Antibody Approved for US Trial (in: Trials & Approvals)
 
Login